Skip to content

Trevi Therapeutics, Inc. TRVI Current Federal, State and Local, Tax Expense (Benefit)

Current Federal, State and Local, Tax Expense (Benefit) at other companies

TRV
Trevi Therapeutics, Inc.TRVI
-$16K-113%
Selective Insurance Group logo
Selective Insurance GroupSIGI
$30.42M-9.4%
Two Harbors Investment Corporation logo
Two Harbors Investment CorporationTWO
$4.29M+33.1%
SolarEdge Technologies logo
SolarEdge TechnologiesSEDG
$650.25K-35.6%
ACM Research logo
ACM ResearchACMR
$2.16M+1,680%
Popular logo
PopularBPOP
$15.05M+17.4%

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.49B+152%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit.

The official record: Trevi Therapeutics, Inc.’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s current federal, state and local, tax expense (benefit).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s current federal, state and local, tax expense (benefit)?
Trevi Therapeutics, Inc. (TRVI) reported current federal, state and local, tax expense (benefit) of -$16K in Q4 2025.
How has Trevi Therapeutics, Inc.'s current federal, state and local, tax expense (benefit) changed year-over-year?
Trevi Therapeutics, Inc.'s current federal, state and local, tax expense (benefit) decreased by 113.3% year-over-year, from -$7.5K to -$16K.
What is the long-term trend for Trevi Therapeutics, Inc.'s current federal, state and local, tax expense (benefit)?
Over 4 years (2021 to 2025), Trevi Therapeutics, Inc.'s current federal, state and local, tax expense (benefit) has grown at a 32.1% compound annual growth rate (CAGR), from -$21K to -$64K.
What does current federal, state and local, tax expense (benefit) mean?
Represents the total current income tax expense or benefit across all domestic jurisdictions, including federal, state, and local levels. This figure excludes deferred tax adjustments and reflects the cash-based tax obligations or refunds for the current fiscal period. It provides a view of the immediate tax burden on the company's operations.